I/A - ROCKET PHARMACEUTICALS, INC. (0001281895) (Subject) — SEC SC TO Filing
HealthcareNew JerseyOther
Rocket Pharmaceuticals
May 28, 2026
Healthcare M&A Deals in New Jersey
24 dealsTracking 24 healthcare M&A deals in New Jersey. Recent activity spans Pharmacy, Healthcare Services Other, Medical Devices, Pharmaceuticals. New Jersey ranks #4 of 41 states for healthcare deal volume.
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
HealthcareNew JerseyPlatform
Tevogen Bio Holdings
May 28, 2026
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
HealthcareNew JerseyOther
May 21, 2026
Amanat Acquisition Corp Announces Pricing of $75 Million Initial Public Offering
HealthcareNew JerseyPlatform
May 19, 2026
Sun Pharma Signs Definitive Agreement to Acquire Organon & Company in $11.75 Billion Deal - India IPO
HealthcareNew JerseyMerger
Sun Pharma→Organon
May 7, 2026
Teva (TEVA) Announces Acquisition of Emalex Biosciences - GuruFocus
HealthcareNew JerseyMerger
Teva→Emalex Biosciences
Apr 29, 2026
Sun Pharma to acquire Organon in USD 11.75 billion deal
HealthcareNew JerseyMerger
Sun Pharma→Organon
Apr 28, 2026
Sun Pharma to acquire Organon in $11.75 billion all-cash deal
HealthcareNew JerseyMerger
Sun Pharma→Organon
Apr 28, 2026
VYNE Therapeutics Inc. — SEC S-4/A Filing
HealthcareNew JerseyMerger
Yarrow Bioscience
Apr 28, 2026
Sun Pharma Signs Definitive Agreement to Acquire Organon - New Jersey Business Magazine
HealthcareNew JerseyMerger
Sun Pharma→Organon
Apr 27, 2026
Sun Pharma to acquire Organon in $11.75 billion all-cash deal - Business Today
HealthcareNew JerseyPlatform
Sun Pharmaceutical Industries→Organon
Apr 27, 2026
Sun Pharma strikes $11.7 billion deal to acquire Organon
HealthcareNew JerseyMerger
Sun Pharmaceutical Industries→Organon
Apr 27, 2026
Organon & Co. — SEC 8-K Filing
HealthcareNew JerseyMerger
Sun Pharma→Organon
Apr 27, 2026
T/A - Merck & Co., Inc. (0000310158) (Filed by) — SEC SC TO Filing
HealthcareNew JerseyMerger
Merck→Terns Pharmaceuticals
Apr 24, 2026
Amneal Agrees to Acquire Kashiv BioSciences to Create - GlobeNewswire
HealthcareNew JerseyPlatform
Amneal→Kashiv BioSciences
Apr 22, 2026
JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering
HealthcareNew JerseyPlatform
JATT II Acquisition
Apr 20, 2026
Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout
HealthcareNew JerseyPlatform
Eli Lilly→Kelonia Therapeutics
Apr 20, 2026
JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
HealthcareNew JerseyPlatform
Apr 16, 2026
C - ROCKET PHARMACEUTICALS, INC. (0001281895) (Subject) — SEC SC TO Filing
HealthcareNew JerseyOther
Rocket Pharmaceuticals
Apr 3, 2026
SCYNEXIS INC — SEC 8-K Filing
HealthcareNew JerseyAdd-on
SCYNEXIS→PXL-770
Mar 31, 2026